Bone marrow stromal cells (BMSCs) may create a CXCL12 gradient to promote the migration of CLL B cells, which promotes fludarabine resistance in CLL [65]. The gene discussed is CXCL12; the disease is B-cell chronic lymphocytic leukemia.